Literature DB >> 27770043

A USE1ful Biomarker and Molecular Target in Lung Cancer?

Wanping Xu1, Len Neckers1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27770043      PMCID： PMC6059118          DOI： 10.1093/jnci/djw227

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  9 in total

1.  Plk1 regulates activation of the anaphase promoting complex by phosphorylating and triggering SCFbetaTrCP-dependent destruction of the APC Inhibitor Emi1.

Authors:  David V Hansen; Alexander V Loktev; Kenneth H Ban; Peter K Jackson
Journal:  Mol Biol Cell       Date:  2004-10-06       Impact factor: 4.138

2.  USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis.

Authors:  Annette Aichem; Christiane Pelzer; Sebastian Lukasiak; Birte Kalveram; Paul W Sheppard; Neha Rani; Gunter Schmidtke; Marcus Groettrup
Journal:  Nat Commun       Date:  2010-05-04       Impact factor: 14.919

3.  Alternative ubiquitin activation/conjugation cascades interact with N-end rule ubiquitin ligases to control degradation of RGS proteins.

Authors:  Peter C W Lee; Mathew E Sowa; Steven P Gygi; J Wade Harper
Journal:  Mol Cell       Date:  2011-08-05       Impact factor: 17.970

4.  Impairment of social behavior and communication in mice lacking the Uba6-dependent ubiquitin activation system.

Authors:  Ji Yeon Lee; Minseok Kwak; Peter C W Lee
Journal:  Behav Brain Res       Date:  2014-12-15       Impact factor: 3.332

Review 5.  Bortezomib: A Review in Mantle Cell Lymphoma in Previously Untreated Patients Unsuitable for Stem-Cell Transplantation.

Authors:  Paul L McCormack
Journal:  BioDrugs       Date:  2015-06       Impact factor: 5.807

Review 6.  Targeting the ubiquitin E1 as a novel anti-cancer strategy.

Authors:  Wei Xu; Julie L Lukkarila; Sara R da Silva; Stacey-Lynn Paiva; Patrick T Gunning; Aaron D Schimmer
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 7.  The therapeutic target Hsp90 and cancer hallmarks.

Authors:  Yoshihiko Miyata; Hitoshi Nakamoto; Len Neckers
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

8.  Regulator of G-protein signaling 4: A novel tumor suppressor with prognostic significance in non-small cell lung cancer.

Authors:  Chuanle Cheng; Weiming Yue; Lin Li; Shuhai Li; Cun Gao; Libo Si; Hui Tian
Journal:  Biochem Biophys Res Commun       Date:  2015-11-27       Impact factor: 3.575

Review 9.  Insights into APC/C: from cellular function to diseases and therapeutics.

Authors:  Zhuan Zhou; Mingjing He; Anil A Shah; Yong Wan
Journal:  Cell Div       Date:  2016-07-13       Impact factor: 5.130
  9 in total
  2 in total

Review 1.  UBA6 and Its Bispecific Pathways for Ubiquitin and FAT10.

Authors:  Fengting Wang; Bo Zhao
Journal:  Int J Mol Sci       Date:  2019-05-07       Impact factor: 5.923

2.  Galangin/β-Cyclodextrin Inclusion Complex as a Drug-Delivery System for Improved Solubility and Biocompatibility in Breast Cancer Treatment.

Authors:  Zainab S Abbas; Ghassan M Sulaiman; Majid S Jabir; Salman A A Mohammed; Riaz A Khan; Hamdoon A Mohammed; Amal Al-Subaiyel
Journal:  Molecules       Date:  2022-07-15       Impact factor: 4.927
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.